A study reveals the long-term effects of a new medication for treating high blood pressure.

A recent scientific study revealed promising results for the drug "Paxlovid," which targets one of the common causes of high blood pressure. The results showed that its effect in lowering blood pressure lasts for up to two years after discontinuation.

The study included 14 patients suffering from primary hyperaldosteronism, a disorder that leads to increased secretion of the hormone aldosterone, causing high blood pressure. The results indicated that about a quarter of the participants were able to stop all blood pressure medications while maintaining normal levels.

The drug works by inhibiting the enzyme responsible for producing the hormone aldosterone, which reduces its secretion and effect in raising blood pressure.

Researchers emphasized the necessity of conducting broader studies to confirm the sustainability of this effect, and not to hasten to conclude that patients have fully recovered.

Researchers believe that the drug may open new horizons for treating this type of high blood pressure and may change the methods of its diagnosis and treatment in the future.